STO · H100.ST
H100 Group AB
SEK 2.03+SEK 0.08 (+3.89%)
H100 Group AB: Technology · Software - Application.
Loading market information…
XETRA · APPH.DE · EUR
Stock price, earnings
Quote as of Nov 14, 2025, 11:17 AM UTC. Cached market data; not a live quote.
One-year closing-price history · EUR. Historical prices are not a forecast.
Apontis Pharma AG’s quoted price sits in the lower half of its reported 52-week range, 10.93% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Apontis Pharma AG’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Operating within Germany, Apontis Pharma AG specializes in the marketing and distribution of pharmaceutical products, with a particular emphasis on internal medicine. The company is actively involved in the development, promotion, and commercialization of a diverse portfolio, which includes combination single-pill therapies and other medications. Key therapeutic areas of focus encompass cardiovascular diseases, such as high blood pressure (hypertension), elevated cholesterol (hyperlipidemia), and strategies for secondary prevention, in addition to respiratory ailments and diabetes. Established in 1946, Apontis Pharma AG maintains its corporate headquarters in Monheim am Rhein, Germany.
Latest available per-share figures in EUR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 03:17 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
SEK 2.03+SEK 0.08 (+3.89%)
H100 Group AB: Technology · Software - Application.
€525.00+€5.00 (+0.96%)
LIMES Schlosskliniken AG’s quoted price sits in the upper half of its reported 52-week range, 11.76% below the high.
€28.40+€0.20 (+0.71%)
MPH Health Care AG’s quoted price sits in the upper half of its reported 52-week range, 4.38% below the high.
€2.14€0.00 (0.0%)
Heidelberg Pharma AG’s quoted price sits in the lower half of its reported 52-week range, 35.93% below the high.
£5.30£0.00 (0.0%)
4basebio PLC’s quoted price sits in the lower half of its reported 52-week range, 35.37% below the high.
€2.78+€0.22 (+8.59%)
BRAIN Biotech AG’s quoted price sits in the lower half of its reported 52-week range, 28.53% below the high.
€10.50€0.00 (0.0%)
DocCheck AG’s quoted price sits in the lower half of its reported 52-week range, 33.96% below the high.
€2.79€0.00 (0.0%)
FamiCord AG’s quoted price sits in the lower half of its reported 52-week range, 60.98% below the high.
